Sanofi lances the test tubes of the main vaccine design


Illustration image
AFP

The French pharmacy group Sanofi announced the start of the Grand Prix for its main project of anti-Covid-19 vaccine, developed with the British GSK, confirming the table on a lancement from 2021 for this product after a month .

“Sanofi and GSK have launched an international study of phase 3 to evaluate the effectiveness of the candidate vaccine against (covid-19)”, as declared in a communication by the French group, in the days following the announcement of encouraging results. ‘issue of first essays.

Ces derniers, dits de phase 2 et realizés sur quelques centaines de personnes, avaient montre que ce vaccin provoque la production d’antikorps contre le coronavirus chez la plupart des sujets auxquels il a été injecté.

However, these are the announcements that people who have given an idea of ​​the effectiveness against the Covid-19 vaccine, for the GSK fournit adjuvant. The seron effect is due to some 35,000 people in multiple countries, not the United States.

If the results are favored, Sanofi, who is on a train to prepare the production of this vaccine, takes into account a quarterly approval by the principal sanitary authorities.

Cela signifies that, in the best of cases, the Sanofi vaccine will be launched before the first vaccines are distributed in the western world against coronavirus, Pfizer / BioNTech and Moderna.

In the European Union (UE), ceux de Johnson & Johnson et d’AstraZeneca so de dàjà sur le marché depuis des semaines. Plus largement, dans le monde, les vaccins russes Sputnik V et chinois Sinovac jouent aussi un role important dans les campagnes de vaccination.

This tardive arrival is explained by the dysfunctions in the development of the vaccine by Sanofi, which has a lot of countermeasures. Depuis, le groupe ne cesse d’assurer que son produit trouvera tout de même sa place.

To titre, il va à la fois évaluer si ce vaccin est efficace contre le variant dit sud-africain, l’une des principales nouvelles souches du virus, et si on l’utilise en rappel après un autre vaccin.

The agit of a recombinant protein vaccine, a different technology from vaccines given. Sanofi developed for other vaccinations, in the ARN messaging service of Pfizer and Moderna, but it is not possible to have an advanced stage.



Source link

Leave a Comment